PCK2 and neoplasm: The relevance of these findings for tumor biology is highlighted by an initial analysis of the expression of PCK2 in tumors from the GDC Pan-Can dataset showing increased expression of the gene in tumors presenting missense variant mutations as compared to non-variant samples (Fig. 5f).